Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Genetic amplification (NAAT) test detects HIV more effectively than standard tests in urban study

28.02.2005


Adding a new HIV screening method, called nucleic acid amplification testing (NAAT), to standard HIV testing, researchers were able to uncover six percent more cases of HIV infection in urban STD and drug treatment clinics and HIV testing sites in Atlanta than with standard HIV antibody tests alone. The research will be presented at the 12th Conference on Retroviruses and Opportunistic Infections in Boston on February 25, 2005 by Frances Priddy, MD, assistant professor of medicine at Emory University School of Medicine.



Physician/researchers at Emory, the University of North Carolina at Chapel Hill and the Georgia Department of Human Resources used NAAT to screen clients receiving routing HIV testing and counseling at the urban clinics between October 2002 and January 2004. The research team used both standard antibody testing and NAAT testing to screen specimens from 2,202 people who had not previously tested positive for HIV. Sixty-six of the specimens were found to be HIV antibody positive and 2,135 were HIV antibody negative using standard tests. Using NAAT, however, four of the antibody-negative specimens tested positive for HIV viral genes.

On further examination, three of those four individuals were found to have definite acute HIV infections, although only one showed clinical symptoms. One of the four individuals had unclear results and may have had either acute or chronic HIV. In addition, three of the four individuals had HIV viruses with multidrug resistance. The fourth sample was unable to be tested for resistance.


Although standard tests that measure antibody response to the HIV virus have become increasingly sensitive, cases of HIV are occasionally missed because individuals can have negative antibody tests during the early stages of infection. Also, a few people with long-term HIV infection may have false-negative antibody tests or may be chronic carriers who are clinically asymptomatic. The NAAT test helps avoid these problems because it amplifies the HIV viral RNA and detects viral genes instead of viral antibodies or antigens.

NAAT testing has been used in the U.S. as an investigational screening test for donated blood since 1999 and was approved for use in 2002 by the FDA. According to a study by the National Institutes of Health (New England J. of Medicine, Aug. 19, 2000), the test has helped prevent the transmission of approximately five HIV-1 infections and 56 hepatitis C virus infections each year since it was initiated for screening donor blood.

"Adding NAAT-based screening to standard HIV testing for can identify people with acute HIV infection earlier when they may be most infectious and at risk for spreading the virus. Then they can be referred for prevention and treatment services earlier before they develop clinical symptoms," Dr. Priddy says. "Early detection and intervention for patients with acute HIV infection may be key in stopping the spread of drug-resistant HIV. Our results show that urban STD and drug clinics and HIV testing sites should consider adopting HIV testing that includes NAAT."

Holly Korschun | EurekAlert!
Further information:
http://www.emory.edu

More articles from Studies and Analyses:

nachricht Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde

nachricht Rutgers-led innovation could spur faster, cheaper, nano-based manufacturing
14.02.2018 | Rutgers University

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Tiny microenvironments in the ocean hold clues to global nitrogen cycle

23.04.2018 | Earth Sciences

Joining metals without welding

23.04.2018 | Trade Fair News

Researchers illuminate the path to a new era of microelectronics

23.04.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>